Primary vaginal leiomyosarcomas (pvLMS) are rare, recurrent tumours accounting for ca. 2% of all vaginal cancers. The etiology is still unknown, the prognosis is poor and there is no consensus guideline on its management. Diagnosis is usually made during the 5th decade due to the presence of a vaginal mass or nodule [1-2]. Current medical literature reports about 200 cases (PubMed®); only 3 studies have considered the ultrastructure [2-4]. Herein a pvLMS is presented and discussed. A nodular, 25 x 23 x 28 mm-mass, infiltrating the urethra but not the rectovaginal septum, was widely excised from the superior vaginal wall of a 58-year-old previously hysterectomized woman. Macroscopic images and MRI were performed. Iliac lymph nodes an...
Objectives: Leiomyomas are benign mesenchymal tumors that consist of smooth muscle cells and varying...
Sarcomas represent only 1% to 3% of vulvar malignancies. Leiomyosarcoma is a rare malignant tumor of...
Uterine sarcomas are an uncommon and heterogeneous group of tumors that account for 3-7% of the mali...
Primary vaginal leiomyosarcomas (pvLMS) are rare, recurrent tumours accounting for ca. 2% of all vag...
Objective: Primary vaginal leiomyosarcomas (LMS) are rare, easily recurrent tumours with an unknown ...
Primary vaginal leiomyosarcomas (LMS) are rare, recurrent tumours with an unknown etiology; the prog...
Introduction/Background Primary vaginal leiomyosarcomas (LMS) are rare, recurrent tumours with an un...
Leiomyomas are classified as benign mesenchymal neoplasms and consist of smooth muscle cells with va...
Background. Primary leiomyosarcoma of the vagina is an exceedingly rare diagnosis. Current estimates...
Aims: We present this case to improve medical knowledge about unusual presentation of leiomyomas an...
Abstract Background Uterine leiomyosarcomas are very rare and highly aggressive tumors that have a h...
Extrauterine leiomyomas are rare and are a great diagnostic challenge. Leiomyoma and fibroma are the...
Aims: We present this case to improve medical knowledge about unusual presentation of leiomyomas and...
Uterine leiomyosarcomas are rare aggressive tumors, with high recurrence rates, even when confined t...
Primary ovarian leiomyosarcomas is a rare neoplasm which comprises less than 3% of ovarian tumors. T...
Objectives: Leiomyomas are benign mesenchymal tumors that consist of smooth muscle cells and varying...
Sarcomas represent only 1% to 3% of vulvar malignancies. Leiomyosarcoma is a rare malignant tumor of...
Uterine sarcomas are an uncommon and heterogeneous group of tumors that account for 3-7% of the mali...
Primary vaginal leiomyosarcomas (pvLMS) are rare, recurrent tumours accounting for ca. 2% of all vag...
Objective: Primary vaginal leiomyosarcomas (LMS) are rare, easily recurrent tumours with an unknown ...
Primary vaginal leiomyosarcomas (LMS) are rare, recurrent tumours with an unknown etiology; the prog...
Introduction/Background Primary vaginal leiomyosarcomas (LMS) are rare, recurrent tumours with an un...
Leiomyomas are classified as benign mesenchymal neoplasms and consist of smooth muscle cells with va...
Background. Primary leiomyosarcoma of the vagina is an exceedingly rare diagnosis. Current estimates...
Aims: We present this case to improve medical knowledge about unusual presentation of leiomyomas an...
Abstract Background Uterine leiomyosarcomas are very rare and highly aggressive tumors that have a h...
Extrauterine leiomyomas are rare and are a great diagnostic challenge. Leiomyoma and fibroma are the...
Aims: We present this case to improve medical knowledge about unusual presentation of leiomyomas and...
Uterine leiomyosarcomas are rare aggressive tumors, with high recurrence rates, even when confined t...
Primary ovarian leiomyosarcomas is a rare neoplasm which comprises less than 3% of ovarian tumors. T...
Objectives: Leiomyomas are benign mesenchymal tumors that consist of smooth muscle cells and varying...
Sarcomas represent only 1% to 3% of vulvar malignancies. Leiomyosarcoma is a rare malignant tumor of...
Uterine sarcomas are an uncommon and heterogeneous group of tumors that account for 3-7% of the mali...